Log In
BCIQ
Print this Print this
 

ATx09-002 (PSN-357)

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionGlycogen phosphorylase inhibitor
Molecular Target Glycogen phosphorylase
Mechanism of ActionGlycogen phosphorylase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationNeuralgia
Indication DetailsTreat post-herpetic neuralgia (PHN)
Regulatory Designation
PartnerAestus Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/26/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today